Contact
Please use this form to send email to PR contact of this press release:
JHL Biotech to Develop and Manufacture GMP-grade Antigen for Taiwan’s Leading Covid-19 Vaccine Produced by Adimmune
TO:
Urania Lee
JHL Biotech, Inc.
+886 36583899